Growth Hormone Deficiency in Children Completed Phase 3 Trials for Somapacitan (DB15093)

IndicationStatusPhase
DBCOND0034025 (Growth Hormone Deficiency in Children)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04970654A Research Study in Chinese Children With a Low Level of Hormone to Grow. Treatment is Somapacitan Once a Week Compared to Norditropin® Once a Day.Treatment